Trial NCT00892866

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Major Program(s) or Research Group(s)

  • Community Oncology and Prevention Trials
  • NCI Community Oncology Research Program

Sponsor

Gynecologic Oncology Group

Status

Active, not recruiting

ClinicalTrials.gov ID

For more information, see ClinicalTrials.gov NCT00892866

This research trial studies carbonic anhydrase 9 (CA-IX), p16, proliferative markers, and
human papilloma virus (HPV) in diagnosing cervical lesions in patients with abnormal cervical
cells. Studying biomarkers in abnormal cervical cells may improve the ability to find
cervical lesions and plan effective treatment.

Intervention

Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis

Condition

Atypical Endometrial Hyperplasia, Human Papillomavirus Infection, Stage 0 Cervical Cancer AJCC v7

Investigators

Shu-Yuan liao

See list of participating sites